Terms And Conditions
  1. Home
  2. Terms And Conditions
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD): A...
By ACE Investors / 17 Apr 2024
Read More
Starpharma Holdings Limited (ASX: SPL): Deliv...
By ACE Investors / 16 Apr 2024
Read More
Dentsply Sirona Inc. (NASDAQ: XRAY): Expandin...
By ACE Investors / 15 Apr 2024
Read More
LTR Pharma Limited (ASX: LTP): Adopted an acc...
By ACE Investors / 12 Apr 2024
Read More
Gilead Sciences, Inc. (NASDAQ: GILD) – Rese...
By ACE Investors / 11 Apr 2024
Read More
Arovella Therapeutics Limited (ASX: ALA): Cap...
By ACE Investors / 10 Apr 2024
Read More
SDI Limited (ASX: SDI): Remains Focused on Re...
By ACE Investors / 10 Apr 2024
Read More
PolyNovo Limited (ASX: PNV) Eyeing on Partner...
By ACE Investors / 09 Apr 2024
Read More
Hologic Inc (NASDAQ: HOLX) – Consistently D...
By ACE Investors / 05 Apr 2024
Read More
Probiotec Limited (ASX: PBP) Actively Pursuin...
By ACE Investors / 27 Mar 2024
Read More
Argenica Therapeutics Limited (ASX: AGN): FDA...
By ACE Investors / 26 Mar 2024
Read More
EBR Systems Inc (ASX: EBR): EBR Announced Pos...
By ACE Investors / 25 Mar 2024
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2024 ACE Investors. All Right Reserved. Design by Ace Investors